Milliman - Capital Group Hedged U.S. Income And Growth Fund ABBV Holdings History
Milliman - Capital Group Hedged U.S. Income and Growth Fund's AbbVie Inc Holding Summary
As of 2025-03-31, Milliman - Capital Group Hedged U.S. Income and Growth Fund held 447.00 shares of AbbVie Inc(ABBV), totaling $93,660.00. This investment constitutes 2.73% of their stock portfolio, and Milliman - Capital Group Hedged U.S. Income and Growth Fund now holds 0% of the outstanding AbbVie Inc(ABBV) stock.
The initial trade took place in 2023Q1. And since then Milliman - Capital Group Hedged U.S. Income and Growth Fund has made 6 purchases of ABBV, at an average price of $167.10, for a total of 636.00 shares. In addition, there have been 2 sales at an average price of $186.84 for 189.00 shares. Based on historical transaction data and ABBV's current price of $187.63, Milliman - Capital Group Hedged U.S. Income and Growth Fund's estimated gain on his ABBV holdings is $12,908.95, reflecting a 12.15% gain to date.
Milliman - Capital Group Hedged U.S. Income and Growth Fund ABBV ($187.63) Holding Chart
Milliman - Capital Group Hedged U.S. Income and Growth Fund ABBV ($187.63) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
